TD Cowen’s recent upgrade of Array Technologies (ARRY) has refocused attention on the solar tracker maker, as the firm cited improving execution, muted expectations, and a valuation gap versus peers.
Abstract: The effect of light illumination intensity on the stability of In-Zn-Sn-O (IZTO) thin-film transistors (TFTs) array fabricated by solution processed is investigated. Comparison with positive ...
Europe salvages credibility with $105 billion loan for Ukraine but shelves plan to use Russian funds
European Union leaders reached a deal early Friday on a $105 billion loan to keep Ukraine’s economy and military from a budgetary blackhole through 2027. While it didn’t come about in the way some of ...
EUREKA, Calif., and ZHANGBEI COUNTY, China– Twenty miles off the misty northern coast of California, off of Humboldt Bay, there's a plan to build offshore wind turbines to power more than two million ...
There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
I've ran into an issue in some legacy project after upgrading to version 2.1.25. Basically there are two maps and one of them is used dynamically. PHPStan seems to ...
September 13th is Positive Thinking Day. While we don’t need a day to recognize the importance and value that positivity can have in our lives, reminders can be helpful. We are all human, and it’s not ...
Albuquerque-based Array Technologies reported Thursday a 20% jump in revenue from the previous quarter, beating analyst expectations. In an earnings call, company officials reported $362.2 million in ...
Nicole Fallon-Peek is a freelance journalist who has covered small business, careers and finance for 15 years. She is a small business owner and former managing editor of Business News Daily. Her work ...
Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...
VEGA-3 trial showed significant efficacy of phentolamine ophthalmic solution 0.75% in improving near vision in presbyopia patients compared to placebo. The trial met its primary endpoint with 27.2% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results